876
Participants
Start Date
July 8, 2019
Primary Completion Date
October 23, 2020
Study Completion Date
October 23, 2020
AXS-05 (dextromethorphan and bupropion) oral tablets
Oral tablets, taken twice daily for up to 12 months.
Clinical Research Site, Staten Island
Clinical Research Site, Jamaica
Clinical Research Site, Rochester
Clinical Research Site, Media
Clinical Research Site, Philadelphia
Clinical Research Site, Raleigh
Clinical Research Site, Hickory
Clinical Research Site, Atlanta
Clinical Research Site, Atlanta
Clinical Research Site, Jacksonville
Clinical Research Site, Orlando
Clinical Research Site, Hialeah
Clinical Research Site, Hollywood
Clinical Research Site, Coral Springs
Clinical Research Site, Miami
Clinical Research Site, North Miami
Clinical Research Site, Lauderhill
Clinical Research Site, Memphis
Clinical Research Site, Middleburg Heights
Clinical Research Site, Cincinnati
Clinical Research Site, Cincinnati
Clinical Research Site, Chicago
Clinical Research Site, Little Rock
Clinical Research Site, Oklahoma City
Clinical Research Site, Dallas
Clinical Research Site, Fort Worth
Clinical Research Site, Wichita Falls
Clinical Research Site, Houston
Clinical Research Site, San Antonio
Clinical Research Site, Austin
Clinical Research Site, Boise
Clinical Research Site, Phoenix
Clinical Research Site, Las Vegas
Clinical Research Site, Beverly Hills
Clinical Research Site, Culver City
Clinical Research Site, Bellflower
Clinical Research Site, Panorama City
Clinical Research Site, Sherman Oaks
Clinical Research Site, Upland
Clinical Research Site, Oceanside
Clinical Research Site, San Diego
Clinical Research Site, Redlands
Clinical Research Site, Garden Grove
Clinical Research Site, Oakland
Clinical Research Site, Bellevue
Clinical Research Site, Everett
Clinical Research Site, Cromwell
Clinical Research Site, Boston
Clinical Research Site, Berlin
Clinical Research Site, Cherry Hill
Clinical Research Site, Toms River
Lead Sponsor
Axsome Therapeutics, Inc.
INDUSTRY